Form D · Other Investment Fund

Biomedical Innovation Opportunities Ltd

Grand Cayman, E9 · CIK 0001969161

Offering snapshot reported Apr 1, 2025 · SEC filing

Reported sold
$10M
Indefinite offering
Investors reported
1
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Feb 27, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5M$10MMar 14, 2023: $10,000,000.00Mar 14, 2023Mar 6, 2024: $10,000,000.00Mar 6, 2024Apr 1, 2025: $10,000,000.00Apr 1, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 1, 2025Amendment$10,000,000$0vs Mar 6, 20241SEC filing
Mar 6, 2024Amendment$10,000,000$0vs Mar 14, 20231SEC filing
Mar 14, 2023Initial$10,000,000No comparison1SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-475848

Source: Form D, filed Apr 1, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

BIOMEDICAL INNOVATION OPPORTUNITIES LTD.

Investment adviser: BLACKROCK FINANCIAL MANAGEMENT, INC

Gross asset value
$67.1K
Beneficial owners
1
ADV minimum commitment
$1M

Reported in Form ADV on Aug 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator JPMORGAN CHASE BANK, N.A. DUBLIN, Ireland Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →
Auditor PRICEWATERHOUSECOOPERS CAYMAN ISLANDS PHILADELPHIA, Pennsylvania, United States Other funds reporting this name →
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

PRICEWATERHOUSECOOPERS CAYMAN ISLANDS
PCAOB 238

Fund asset history · 3 annual observations Gross asset value by annual ADV filing$0$11.7M$23.5MFY 2023: $23,450,226.00FY 2023FY 2024: $23,450,226.00FY 2024FY 2025: $67,095.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2023$23,450,2261Mar 28, 2024
2024$23,450,2261Mar 31, 2025
2025$67,0951Mar 31, 2026
Filing source

Form ADV 2128806 · Aug 27, 2026 · Schedule D 7.B.(1), fund 805-6495046271

Reported by BLACKROCK FINANCIAL MANAGEMENT, INC (CRD 107105).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jennifer Collins Director
Noelle L'heureux Director
Ian Pilgrim Director
W. William Woods Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
Ugland House
Grand Cayman, E9, KY1-1104
Phone: 345-949-8066